RT Generic
T1 104-week safety and effectiveness of dupilumab in the treatment of severe atopic dermatitis. The experience of 5 reference dermatology units in Spain
A1 Juan Pereyra-Rodriguez, Jose
A1 Dominguez-Cruz, Javier
A1 Carlos Armario-Hita, Jose
A1 Ruiz-Villaverde, Ricardo
PB Elsevier science inc
SN 0365-0596
YR 2021
FD 2021-11-09
LK http://hdl.handle.net/10668/18667
UL http://hdl.handle.net/10668/18667
LA en
DS RISalud
RD Apr 11, 2025